2019
DOI: 10.1080/09273948.2019.1623268
|View full text |Cite
|
Sign up to set email alerts
|

Intravitreal Bevacizumab for Treatment of Bilateral Candida Chorioretinitis Complicated with Choroidal Neovascularization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…1,2,38,39 Antimicrobial therapy should be added in eyes with CNV in the setting of active toxoplasmic or tuberculous retinochoroiditis. Four Original Articles [40][41][42][43] and two Letters 44,45 in this issue of Ocular Immunology & Inflammation (OII) describe the occurrence, clinical and multimodal imaging features, and management of CNV in the setting of uveitis.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…1,2,38,39 Antimicrobial therapy should be added in eyes with CNV in the setting of active toxoplasmic or tuberculous retinochoroiditis. Four Original Articles [40][41][42][43] and two Letters 44,45 in this issue of Ocular Immunology & Inflammation (OII) describe the occurrence, clinical and multimodal imaging features, and management of CNV in the setting of uveitis.…”
mentioning
confidence: 99%
“…Zonnevylle and Stanescu-Segall 45 described an 83year-old man who develop Candida albicans chorioretinitis in the setting of post-surgical candidemia complicated by the formation of bilateral type 2 CNV. The active infection and CNV were treated with systemic fluconazole and a combination of intravitreal amphotericin B followed by a series of 11 monthly injections of bevacizumab in the right eye and 12 monthly injections in the left eye.…”
mentioning
confidence: 99%